Global Burden of Disease 2005: call for collaborators

TY - JOUR

T1 - Global Burden of Disease 2005

T2 - call for collaborators

AU - Murray, Christopher JL

AU - Lopez, Alan D.

AU - Black, Robert

AU - Mathers, Colin D.

AU - Shibuya, Kenji

AU - Ezzati, Majid

AU - Salomon, Joshua A.

AU - Michaud, Catherine M.

AU - Walker, Neff

AU - West, Sheila K

N1 - Funding Information: Christopher JL Murray a cjlm@u.washington.edu Alan D Lopez b Robert Black c Colin D Mathers d Kenji Shibuya d Majid Ezzati e Joshua A Salomon e Catherine M Michaud e Neff Walker c Theo Vos b a Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA 98104, USA b School of Population Health, University of Queensland, Brisbane, QLD, Australia c Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA d Department of Measurement and Health Information Systems, WHO, Geneva, Switzerland e Harvard School of Public Health, Boston, MA, USA The Global Burden of Disease (GBD) Study was commissioned by the World Bank in 1991 to provide a comprehensive assessment of disease burden in 1990 for 107 diseases and injuries and ten selected risk factors for the world and eight major regions. 1 The methods and findings of the original GBD have been widely published 2,3 and have stimulated numerous national studies of burden of disease. 4–8 The basic philosophy guiding the burden of disease approach is that best estimates of incidence, prevalence, and mortality can be generated through the careful analysis and correction for bias of all available sources of information in a country or region. To assess burden of disease, a time-based measure that combined years of life lost due to premature mortality and years of life lost due to time lived in health states less than ideal health—the disability-adjusted life year, or DALY—was developed. The initial GBD Study represented a major step in the global and regional quantification of the effects of diseases, injuries, and risk factors on population health. Results from the GBD Study have been widely used by governments and non-governmental agencies to inform debates on priorities for research, development, and policy responses. In 2000, WHO began publishing on a regular basis 9 updates of the GBD for the world and 14 regions. These revisions were aided by methodological improvements and more extensive data collection that covered key domains of the study, including mortality estimation, cause of death analysis, and measurement and valuation of functional health status. 10–12 Standardised concepts and approaches to comparative risk assessment were applied to over 25 risk factors. 13 New estimates for 2001 were published as part of the second revision of the Disease Control Priorities Project. 14 In addition to these continuing efforts for better epidemiological quantification, the philosophical underpinnings for quantifying population health have also been extensively explored as part of the overall effort to foster summary measures of population health. 15 Despite these considerable efforts and refinements, important opportunities remain to greatly advance the quantification of the burden of disease. First, there has not been a complete systematic assessment of the data on all diseases and injuries since the original GBD Study. Second, new sources of primary data, such as vital statistics, Demographic and Health Surveys, Multiple Indicator Cluster Surveys, World Health Surveys, and several national health interview and examination surveys, have become available. Third, new methods for estimating adult mortality, analysing verbal autopsy data, modelling cause-of-death composition, computing attributable fractions for multiple risk factors, correcting for differential item functioning in health surveys, and imposing internal consistency constraints can be brought to bear. Fourth, better population-based methods and data are available to develop improved disability weights for the health states included in the GBD Study. Finally, there is a much larger community of epidemiologists and public-health specialists who are familiar with burden of disease concepts and methods in many countries and regions. Through a grant from the Bill & Melinda Gates Foundation, a consortium led by the Institute for Health Metrics and Evaluation , and involving WHO, the University of Queensland, and the Johns Hopkins and Harvard universities, is revising the GBD for 1990 and 2005 (GBD2005) . This effort will take 3 years and produce new estimates of the burden of disease for more than 150 diseases and injuries and more than 25 risk factors, for 20 regions of the world. GBD2005 will not only serve to systematically incorporate the evidence on each major disease and risk factor into a coherent set of epidemiological estimates, but will also provide an opportunity for concerted work on new age-specific and sex-specific mortality estimates, disability weight measurement, estimation of probabilities of disabling sequelae, and standardisation of tools and methods for resolving inconsistencies, dealing with missing data and quantifying uncertainty. Science Photo Library Much of the work will be organised around 35 expert groups. To make sure GBD2005 incorporates the broadest possible knowledge and expertise in individual diseases or risk factor areas, we are inviting anyone who is interested in collaborating on this project to express interest. The study website provides further details on the definition of the expert groups, how to express interest, the process for final selection of the disease expert groups, and the restricted resources available to support work by these expert groups. In view of the timeline of the project, investigators interested in participating are encouraged to express interest as soon as possible, preferably before the end of July, 2007. We declare that we have no conflict of interest. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2007/7/14

Y1 - 2007/7/14

UR - http://www.scopus.com/inward/record.url?scp=34447249352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447249352&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(07)61064-2

DO - 10.1016/S0140-6736(07)61064-2

M3 - Comment/debate

C2 - 17630021

AN - SCOPUS:34447249352

SN - 0140-6736

VL - 370

SP - 109

EP - 110

JO - Lancet

JF - Lancet

IS - 9582

ER -